Literature DB >> 9767746

The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis.

G L Daniels1, B H Faas, C A Green, E Smart, P A Maaskant-van Wijk, N D Avent, H A Zondervan, A E von dem Borne, C E van der Schoot.   

Abstract

BACKGROUND: VS and V are common red cell antigens in persons of African origin. The molecular background of these Rh system antigens is poorly understood. STUDY DESIGN AND METHODS: Red cells from 100 black South Africans and 43 black persons from Amsterdam, the Netherlands, were typed serologically for various Rh system antigens. Allele-specific polymerase chain reaction and sequencing of polymerase chain reaction products were used to analyze C733G (Leu245Val) and G1006T (Gly336Cys) polymorphisms in exons 5 and 7 of RHCE and the presence of a D-CE hybrid exon 3.
RESULTS: The respective frequencies of all VS+ and of VS+ V-(r's) phenotypes were 43 percent and 9 percent in the South Africans and 49 percent and 12 percent in the Dutch donors. All VS+ donors had G733 (Val245), but six with G733 were VS- (4 V+w, 2 V-). The four VS- V+w donors with G733 appeared to have a CE-D hybrid exon 5. T1006 (Cys336) was present in 12 percent and 16 percent of donors from the two populations. With only a few exceptions, T1006, a D-CE hybrid exon 3, and a C410T (Ala137Val) substitution were associated with a VS+ V-phenotype ((C)ces or r's haplotype). Two VS+ V-individuals, with the probable genotype, (C)ces/(C)ces), were homozygous for G733 and for T1006.
CONCLUSIONS: It is likely that anti-VS and anti-V recognize the conformational changes created by Val245, but that anti-V is sensitive to additional conformational changes created by Cys336.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767746     DOI: 10.1046/j.1537-2995.1998.381098440860.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  22 in total

Review 1.  Molecular genetics and clinical applications for RH.

Authors:  Willy A Flegel
Journal:  Transfus Apher Sci       Date:  2011-01-28       Impact factor: 1.764

2.  Non-invasive foetal RHD genotyping in transfusion medicine.

Authors:  Gregory A Denomme
Journal:  Blood Transfus       Date:  2011-11-16       Impact factor: 3.443

3.  Implementing non-invasive RHD genotyping on cell-free foetal DNA from maternal plasma: the Pavia experience.

Authors:  Ilaria Sbarsi; Paola Isernia; Laura Montanari; Carla Badulli; Miryam Martinetti; Laura Salvaneschi
Journal:  Blood Transfus       Date:  2011-11-16       Impact factor: 3.443

4.  Insights into RHCE Molecular Analysis in Samples with Partial D Variants: the Experience of Western France.

Authors:  Yann Fichou; Cédric Le Maréchal; Virginie Scotet; Déborah Jamet; Claude Férec
Journal:  Transfus Med Hemother       Date:  2015-07-23       Impact factor: 3.747

5.  Performance evaluation study of ID CORE XT, a high throughput blood group genotyping platform.

Authors:  Mónica López; Izaskun Apraiz; Montserrat Rubia; Mercedes Piedrabuena; Maria Azkarate; Barbera Veldhuisen; Miguel Á Vesga; Ellen Van Der Schoot; Fernando Puente; Diego Tejedor
Journal:  Blood Transfus       Date:  2016-11-25       Impact factor: 3.443

6.  Determination of Fetal RHD Genotype Including the RHD Pseudogene in Maternal Plasma.

Authors:  Karen Chinoca Ziza; Adolfo Wenjaw Liao; Marcia Dezan; Carla Luana Dinardo; Eduardo Jens; Rossana Pulcineli Vieira Francisco; Alfredo Mendrone Junior; Marcelo Zugaib; José Eduardo Levi
Journal:  J Clin Lab Anal       Date:  2016-09-06       Impact factor: 2.352

7.  (C)ce(s) haplotype screening in Tunisian blood donors.

Authors:  Hajer Moussa; Néjiba Ghommen; Houda Romdhane; Saadia Abdelkefi; Taher Chakroun; Batoul Houissa; Saloua Yacoub Jemni
Journal:  Blood Transfus       Date:  2013-12-04       Impact factor: 3.443

8.  DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications.

Authors:  Connie M Westhoff; Sunitha Vege; Christine Halter-Hipsky; Trina Whorley; Kim Hue-Roye; Christine Lomas-Francis; Marion E Reid
Journal:  Transfusion       Date:  2010-01-15       Impact factor: 3.157

Review 9.  Genotyping in Sickle Cell Disease Patients: The French Strategy.

Authors:  Aline Floch; Christophe Tournamille; Btissam Chami; France Pirenne
Journal:  Transfus Med Hemother       Date:  2018-07-06       Impact factor: 3.747

10.  Genotyping approach for non-invasive foetal RHD detection in an admixed population.

Authors:  Carolina Trucco Boggione; Melina E Luján Brajovich; Stella M Mattaloni; René A Di Mónaco; Silvia E García Borrás; Claudia S Biondi; Carlos M Cotorruelo
Journal:  Blood Transfus       Date:  2016-03-21       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.